Despite One Death and One Adverse Event, bluebird bio's Gene Therapy Study Meets Goals

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks4.jpg" NAME"Despite One Death and One Adverse Event, bluebird bio (BLUE)'s Gene Therapy Study Meets Goals" ALT"Despite One Death and One Adverse Event, bluebird bio (BLUE)'s Gene Therapy Study…

Continue ReadingDespite One Death and One Adverse Event, bluebird bio's Gene Therapy Study Meets Goals

Doing it Right: The Man Who Blew Up Theranos Started His Own Medical Testing Biotech

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-research-lab.jpg" NAME"Doing it Right: The Man Who Blew Up Theranos Started His Own Medical Testing Biotech" ALT"Doing it Right: The Man Who Blew Up Theranos Started His Own Medical…

Continue ReadingDoing it Right: The Man Who Blew Up Theranos Started His Own Medical Testing Biotech

<b>Palleon Pharma</b> Bursts Onto the Scene With $47.6 Million and a New R&D Approach

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Palleon Pharma Bursts Onto the Scene With $47.6 Million and a New R&D Approach" ALT"Palleon Pharma Bursts Onto the Scene With $47.6 Million and a New R&D Approach"October…

Continue Reading<b>Palleon Pharma</b> Bursts Onto the Scene With $47.6 Million and a New R&D Approach